Concepedia

Kent Y. Feng

KY

10

Publications

298

Citations

10

H-Index

2014

Active since

Affiliations

Stanford University(Current)

Center for Clinical Research (United States)

Stanford Medicine

Eiger Biopharmaceuticals (United States)

Kaiser Permanente San Francisco Medical Center

Kent Y. Feng is an author at Stanford University specializing in cardiology, public health, and medicine.

ORCID

Top concepts

Publications per year

2014–2023

10

Publications

10

Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial

Prasanna Jagannathan, Jason R. Andrews, Hector Bonilla et al. · Nature Communications · 2021 · 143 citations · Full text

Combining donor derived cell free DNA and gene expression profiling for non‐invasive surveillance after heart transplantation

E. Henricksen, Yasbanoo Moayedi, S. Purewal et al. · Clinical Transplantation · 2022 · 29 citations

Association Between Serum Albumin and Outcomes in Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial

Kent Y. Feng, Andrew P. Ambrosy, Zhipeng Zhou et al. · European Journal of Heart Failure · 2023 · 27 citations · Full text

The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: Analysis of the <scp>CREDENCE</scp> trial

Clare Arnott, Jing‐Wei Li, Christopher P. Cannon et al. · Diabetes Obesity and Metabolism · 2021 · 19 citations · Full text

Developing Clinical Risk Prediction Models for Worsening Heart Failure Events and Death by Left Ventricular Ejection Fraction

Rishi Parikh, Alan S. Go, Ankeet S. Bhatt et al. · Journal of the American Heart Association · 2023 · 17 citations · Full text

, , +19

Rows per page

1–5 of 10